Challenge Triclosan

Recent, high-quality studies show that triclosan-coated sutures are not superior to non-triclosan-coated sutures in preventing surgical site infections (SSI).1 Make the switch to Medtronic.

Triclosan can be controversial.

GreenScreen™* hazard assessment ranks triclosan as a chemical of serious concern to be avoided.

  • Triclosan is considered an environmental toxicant.2
  • Triclosan is a weak agent against the bacteria linked to most SSI.2
  • Overuse of triclosan in a single patient could cause antimicrobial resistence.2

All of Medtronic's sutures are triclosan free.

New studies.
New standards.

  • The NIHR meta-analysis is the first study to use only high quality, unbiased trials.3
  • The FALCON study shows no evidence of difference in the risk of SSI with triclosan-coated sutures versus non-triclosan coated sutures.1
  • The financial burden associated with triclosan-coated sutures is significant.1

No clear benefit

The NIHR meta-analysis and FALCON studies discovered that triclosan-coated sutures show no superiority over non-triclosan-coated sutures in preventing SSI.1

Get in touch

FALCON Study


Triclosan sutures surgeons study
 

NIHR meta-analysis FALCON summary
 

Triclosan sutures procurement study
 

Choose effective, innovative solutions.

From the game-changing V-Loc™ device family to absorbable sutures and beyond, learn more about our triclosan free sutures.

References

1. NIHR Global Research Health Unit on Global Surgery. Reducing surgical site infections in low-income and middle-income countries (FALCON): a pragmatic, multicentre, stratified, randomised controlled trial. The Lancet. 2021;398.

2. Khan R., Yee AL, Gilbert JA et al. Triclosan-containing sutures: safety and resistance issues need to be addressed prior to generalized use. Appl Nanosci. 2022;12: 3061–3070.

3. NIHR Global Research Health Unit on Global Surgery. Alcoholic chlorhexidine skin preparation or triclosan-coated sutures to reduce surgical site infection: a systematic review and meta-analysis of high-quality randomised controlled trials. The Lancet. May 2022.
 

Disclaimer

The material on this website should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s). 
Please note that the intended use of a product may vary depending on geographical approvals. 
See the device manual(s) for detailed information regarding the intended use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events.
For a MRI compatible device(s), consult the MRI information in the device manual(s) before performing a MRI. 
If a device is eligible for eIFU usage, instructions for use can be found at Medtronic’s website manuals.medtronic.com. 
Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser. 
Medtronic products placed on European markets bear the CE mark and the UKCA mark (if applicable). 
For any further information, contact your local Medtronic representative.